Diligence memo · auto-generated · as of July 2, 2026
Return Health Inc.
Return Health Inc. looks under-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Return Health Inc. operates in Pharmaceuticals, based in HIALEAH.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Return Health Inc. has raised $115K in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $115K on 2021-06-24.
Most recent recorded round closed around 2021-06-24.
Valuation (modeled)modeled
Provath models Return Health Inc. at approximately $3.1M (range $64K–$26M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.23× the median modeled value of Pre-Seed Pharmaceuticals companies in 2019–2021 (46 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Last raise 5.0 yr ago; this sector typically re-raises about every 13 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 2% of Pharmaceuticals peers (1613 compared).
Modeled value ranks above 5% of those peers.
Closest niche peers: Elion Oncology, Inc., Cyclone Therapeutics, Inc., Sonnet Biotherapeutics, Inc., Fastball Capital Group, Llc, TamRx, LLC.
Peoplefiled
7 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.